Prolactin and smoking status in antipsychotic-treated patients

Journal of Psychopharmacology

Volumn 25, Issue 5, 2011, Pages 698-703

  MacKin, Paul ^b   Waton, Anthony ^a   Nulkar, Amit ^a   Watkinson, Helen M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antipsychotics; bipolar disorder; hyperprolactinaemia; nicotine; prolactin; schizo affective disorder; schizophrenia; smoking

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PIPOTIAZINE; PROLACTIN; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX RATIO; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PROLACTIN; SMOKING; YOUNG ADULT;

EID: 79955408463     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110379289     Document Type: Article

References (23)

1. Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, et al. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Mol Psychiatry. 2000 ; 5: 410-417 (Pubitemid 30455955)
2. Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 1999 ; 44: 1075-1084 (Pubitemid 30030162)
3. Bushe C, Shaw M. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics. J Psychopharmacol. 2007 ; 21: 768-773 (Pubitemid 47437921)
4. Bushe CJ, Bradley AJ, Wildgust HJ, Hodgson RE. Schizophrenia and breast cancer incidence: a systematic review of clinical studies. Schizophr Res. 2009 ; 114: 6-16
5. Bushe C, Shaw M, Peveler RC. A review of the association between antipsychotic use and hyperprolactinaemia. J Psychopharmacol. 2008a ; 22: 46-55
6. Bushe C, Yeomans D, Floyd T, Smith SM. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics. J Psychopharmacol. 2008b ; 22: 56-62
7. Corona G, Mannucci E, Petrone L, Ricca V, Mansani R, Cilotti A. Psychobiological correlates of smoking in patients with erectile dysfunction. Int J Impot Res. 2005 ; 17: 527-534 (Pubitemid 41581706)
8. Fuxe K, Andersson K, Eneroth P, Harfstrand A, Agnati LF. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology. 1989 ; 14: 19-41 (Pubitemid 19110829)
9. Johnsen E, Kroken RA, Abaza M, Olberg H, Jorgensen HA. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey. J Clin Psychopharmacol. 2008 ; 28: 686-690
10. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology. 2003 ; 28: 69-82 (Pubitemid 36332230)
11. Kirschbaum C, Scherer G, Strasburger CJ. Pituitary and adrenal hormone responses to pharmacological, physical, and psychological stimulation in habitual smokers and nonsmokers. Clin Investig. 1994 ; 72: 804-810 (Pubitemid 24327781)
12. Knegtering H, Van Der , Moolen AE, Castelein S, Kluiter H, Van Den Bosch RJ. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?. Psychoneuroendocrinology. 2003 ; 28: 109-123 (Pubitemid 36335820)
13. Lee PN, Hamling J. Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women: a review with meta-analyses. Inhal Toxicol. 2006 ; 18: 1053-1070 (Pubitemid 44581319)
14. Mansvelder HD, Keath JR, Mcgehee DS. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron. 2002 ; 33: 905-919 (Pubitemid 34246356)
15. Mendelson JH, Sholar MB, Mutschler NH, Jaszyna-Gasior M, Goletiani NV, Siegel AJ, et al. Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Ther. 2003 ; 307: 339-348 (Pubitemid 37151926)
16. Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C. Amisulpride-induced hyperprolactinemia is reversible following discontinuation. Prog Neuropsychopharmacol Biol Psychiatry. 2007 ; 31: 92-96 (Pubitemid 44959254)
17. Peveler RC, Branford D, Citrome L, Fitzgerald P, Harvey PW, Holt RI, et al. Antipsychotics and hyperprolactinaemia: clinical recommendations. J Psychopharmacol. 2008 ; 22: 98-103
18. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Braunig P, Marler M. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry. 1994 ; 35: 151-163 (Pubitemid 24078480)
19. Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 ; 15: 602-611
20. Trummer H, Habermann H, Haas J, Pummer K. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod. 2002 ; 17: 1554-1559 (Pubitemid 34661807)
21. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry. 2003 ; 182: 199-204 (Pubitemid 36286731)
22. Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME. Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology (Berl). 1982 ; 78: 305-308 (Pubitemid 13218563)
23. Xue Y, Morris M, Ni L, Guthrie SK, Zubieta JK, Gonzalez K, et al. Venous plasma nicotine correlates of hormonal effects of tobacco smoking. Pharmacol Biochem Behav. 2010 ; 95: 209-215